Oncology Portfolio - Health Technology Insights

Labcorp Expands Oncology Portfolio to Enhance Patient Care and Cancer Research

May 30, 2025

New test offerings target solid tumors and hematologic malignancies Labcorp, a global leader of innovative and comprehensive laboratory services, announced the expansion of its precision oncology

Biocon Biologics Announces U.S. FDA Approval for Jobevne™, Biosimilar Bevacizumab, Expanding Its Oncology Portfolio

Biocon Biologics Gets FDA Approval for Jobevne Biosimilar

April 10, 2025

Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd ( announced that the U.S. Food and Drug Administration (U.S. FDA) has approved Jobevn (bevacizumab-nwgd), a biosimilar

Categories

Tag: Oncology Portfolio

Labcorp Expands Oncology Portfolio to Enhance Patient Care and Cancer Research

Biocon Biologics Gets FDA Approval for Jobevne Biosimilar

Share With

Recent Posts

Health Technology Insights: Latest News And Innovations – Roundup

NKGen, HekaBio Partner to Expand NK Cell Therapy in Japan

Jeff Keller Named President at Propel Health Unit

Octagos Selected for Microsoft Pegasus Health Program

Big Pharma Accelerates AI Adoption Amid Growing Challenges

Quick Links

Insights

Get in touch

Follow Us

Our Other Brands